Jintai Cultural Institute and Azerbaijan azpropharma pharmaceutical company signed a memorandum of intent on cooperation in traditional Chinese medicine in China Belarus Industrial Park

发布于: 2021-02-23 00:00

On the afternoon of February 23, movsumov, founder of Azerbaijan as Group Investment Co., Ltd., visited the Sino white industrial park and had a discussion with the park development company, Jintai Cultural Institute, CAMCE international and other units on the cooperation of traditional Chinese medicine projects with Jintai Cultural Institute through the Sino white industrial park.

 

 

At the symposium, the participants had a full exchange of views on trade policies and logistics channels for the export of traditional Chinese medicine products to Azerbaijan. After the meeting, Jintai Cultural Institute signed a memorandum of intent with azpropharma pharmaceutical company. According to the memorandum, the two sides will work together to promote the epidemic prevention and antiviral Chinese patent medicine Linglan Xieqing granules in the markets of Azerbaijan and neighboring countries. Wang Yuhang, general manager of CAMCE international and Yan Gang, general manager of Zhongbai industrial park development company witnessed the signing ceremony.

 

Azpropharma is a pharmaceutical company under as investment group. As investment group is an integrated enterprise integrating production, construction and real estate development, headquartered in Baku, Azerbaijan. The main business areas of as investment group include real estate development, construction material production, logistics and transportation, agricultural product production, it engineering, construction and general contracting, heavy machinery and construction machinery, asset management, retail and energy.

 

 

After the meeting, movsumov, Cai Chuanqing, President of Jintai Academy of Arts and culture, and Wang Yuhang, accompanied by Yan Gang and Ren Fei, deputy general manager of China Belarus Industrial Park, inspected China Merchants China Belarus business logistics park and the planning hall of science and innovation center, and learned about the development process and preferential policies of the park.

 

 

Source: Official Website of China Belarus Industrial Park, xinhuanet.com, people.com, reference news, etc

Share

Recommended articles

  • 2021-11-11
      The world's first proprietary Chinese medicine for the treatment of COVID-19 has been released   Zhou Xingting   Yao jian   "Linglan Pesticide-clear" is developed and produced by New Times Biotechnology Co., LTD., a Traditional Chinese medicine enterprise in China-Belarus Industrial Park.     The world's first effective Chinese patent medicine for COVID-19 treatment   Southern Guangdong introduced "linglan epidemic qing" registered sales in Australia    On November 5, on the occasion of the opening of the China International Import Expo, the press conference on Traditional Chinese medicine products of the China-Belarus Industrial Park and the signing ceremony of the cooperation agreement of the China-Belarus Industrial Park jointly hosted by the Belarusian Embassy in China, chin...
  • 2021-11-10
      On January 5, Qingfu Capsule, the world's first pure herbal medicine for COVID-19, was jointly developed by China and Belarus and launched in Shanghai. The drug will be produced in the China-Belarus Industrial Park on the outskirts of Minsk, Belarus.   China-belarus Industrial Park Chinese medicine enterprise new era biological medicine company qingfu capsule launch ceremony     Qingfu Capsule is a pure natural plant extract capsule developed and produced by Dr. CAI Chuanqing of Jintai Cultural Institute of China using modern technology combined with traditional medical essence, which can effectively treat and prevent COVID-19. Since February 2020, Linglan granules have successfully cured COVID-19 patients in many countries, including former Ukrainian Prime Minister Yulia Tymoshenko and president Petro Poros...
  • 2021-11-10
      On November 5, when the China International Import Expo opened, the China-Belarus Industrial Park held a press conference on Traditional Chinese medicine products of the Industrial Park and the signing ceremony of the cooperation agreement between the industrial park, demonstrating the major achievements of china-Belarus anti-epidemic cooperation.     According to reports, qingfu capsule series, originated from the classic formula in Treatises on Typhoid fever 1800 years ago, combined with the successful experience of Traditional Chinese medicine in fighting malignant infectious diseases such as The Outbreak of Blast, combined with modern medicine, in view of novel coronavirus characteristics of rapid transmission, rapid disease progression, high mortality and many sequelae, is a new formula. Novel Coronavirus can effectively inhibit novel Coronavirus, redu...